FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel
pharmaphorum
DECEMBER 9, 2020
The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go. But there are still unanswered questions that can only be addressed once the shot is administered to the wider public. of participants.
Let's personalize your content